Table 5. Meta-regression analyses.
Predictors p-value | ||||
---|---|---|---|---|
BV dosage | Patient’s age | Median duration of follow-up | Median duration of BV therapy | |
PFS | 0.48 | 0.05 | 0.53 | 0.87 |
OS | 0.33 | 0.18 | 0.71 | 0.15 |
ORR | 0.02 | 0.20 | 0.48 | 1.00 |
Abbreviations: PFS: progression free survival; OS: overall survival; ORR: overall response rate; BV: bevacizumab.